Co-Diagnostics, Inc. (CODX): Nasdaq/NYSE listing notice — Co-Diagnostics receives Nasdaq bid price deficiency notice; 180 days to regain compliance

Co-Diagnostics, Inc.

Notice on Jan 10, 2025: closing bid price below $1.00 for 30 consecutive business days.
Compliance date July 9, 2025; must close at $1.00+ for ten consecutive business days.
Stock continues trading on Nasdaq Capital Market under symbol CODX.
If not compliant by July 9, may seek 180-day extension by meeting other listing standards and intending reverse split if needed.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Co-Diagnostics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 10, 2025, Co-Diagnostics, Inc. (“CODX” or “the Company”) received a notice from Nasdaq Listing Qualifications department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the closing bid price

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Co-Diagnostics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

January 10, 2025, Co-Diagnostics, Inc. (“CODX” or “the Company”) received a notice from Nasdaq Listing Qualifications department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the closing bid price of the Company’s common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2). The Company has a period of 180 calendar days, or until July 9, 2025 (the “Compliance Date”), to regain compliance with Listing Rule 5550(a)(2). To regain compliance, the bid price of the Company’s com

View on SEC.gov

Browse all listing & compliance notices →

Co-Diagnostics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-001705

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.